Skip to main content
Reset

Advanced Filters

Advanced Search Help

Standard search functionality is for the search to return results that contain all words entered into the search bar.

Exact Phrase Match Search - Use quotations around a phrase to only return results that are an exact match to the search term entered. Example: "example text"

Exclusion Search - Use the minus sign to only return results that do not include your search term. -example

Either/Or Search - Use the word OR in between words to return results that include either or both words. Example: example OR test

Use advanced filters to allow you to further drill down and limit your search results! Such as selecting two dates to only display matching search results which occur on either of those days.

Search options can be combined in limited ways to increase the accuracy of your search results. Example: A search for "intellectual property" and electrochemistry.

Advanced Filters
  • Displaying 1 - 10 of 37
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last
Patient Awareness of Elevated Breast Cancer Risk After Routine Screening Mammogram and Risk NotificationPatient Awareness of Elevated Breast Cancer Risk After Routine Screening Mammogram and Risk Notification
Patient Awareness of Elevated Breast Cancer Risk After Routine Screening Mammogram and Risk Notification
Rachel J. Mason, MPH, Author
Tags: Member Institution EpidemiologyRisksPrevention
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Rachel J. Mason, MPH

Tags: Member Institution EpidemiologyRisksPrevention
Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to TreatPancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat
Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat
Ms. Nicole Nardella, MS, BS, Author
Tags: Member Institution Outcomes and Health Services Research
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Ms. Nicole Nardella, MS, BS

Tags: Member Institution Outcomes and Health Services Research
Real-World Use of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer Following Prior Ado-trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade with Pertuzumab Plus TrastuzumabReal-World Use of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer Following Prior Ado-trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade with Pertuzumab Plus Trastuzumab
Real-World Use of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer Following Prior Ado-trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade with Pertuzumab Plus Trastuzumab
Kelly E. McCann, MD, Author
Tags: Member Institution Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Kelly E. McCann, MD

Tags: Member Institution Clinical Oncology
Improving Management of Treatment Side Effects Through Chemotherapy Care Kit Delivery in VietnamImproving Management of Treatment Side Effects Through Chemotherapy Care Kit Delivery in Vietnam
Improving Management of Treatment Side Effects Through Chemotherapy Care Kit Delivery in Vietnam
Kelly M. Smith, MD, Author
Tags: Member Institution Quality Improvement
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Kelly M. Smith, MD

Tags: Member Institution Quality Improvement
Baseline Neutrophil to Lymphocyte Ratio and its Change Over Time Predict Overall Survival in Metastatic Non-Small Cell Lung Cancer Patients Who Received First Line Pembrolizumab TherapyBaseline Neutrophil to Lymphocyte Ratio and its Change Over Time Predict Overall Survival in Metastatic Non-Small Cell Lung Cancer Patients Who Received First Line Pembrolizumab Therapy
Baseline Neutrophil to Lymphocyte Ratio and its Change Over Time Predict Overall Survival in Metastatic Non-Small Cell Lung Cancer Patients Who Received First Line Pembrolizumab Therapy
Kenneth Chian, BS, Author
Tags: Member Institution Correlative Genomic
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Kenneth Chian, BS

Tags: Member Institution Correlative Genomic
Electronic Cigarette Exposure on the Growth and Metastasis of Oral Squamous Cell CarcinomaElectronic Cigarette Exposure on the Growth and Metastasis of Oral Squamous Cell Carcinoma
Electronic Cigarette Exposure on the Growth and Metastasis of Oral Squamous Cell Carcinoma
Yibo Xi, PhD, Author
Tags: Member Institution EpidemiologyRisksPrevention
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Yibo Xi, PhD

Tags: Member Institution EpidemiologyRisksPrevention
Optimal Interval Between Immune Therapy and Targeted Therapy with Sotorasib in Patients with KRAS G12C Mutant Non-Small Cell Lung CancerOptimal Interval Between Immune Therapy and Targeted Therapy with Sotorasib in Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer
Optimal Interval Between Immune Therapy and Targeted Therapy with Sotorasib in Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer
Julia Bielanin, BS, BA, Author
Tags: Member Institution Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Julia Bielanin, BS, BA

Tags: Member Institution Clinical Oncology
Committing to Resiliency: Transforming Burnout to Resilience at a National Cancer Institute (NCI) Comprehensive Cancer CenterCommitting to Resiliency: Transforming Burnout to Resilience at a National Cancer Institute (NCI) Comprehensive Cancer Center
Committing to Resiliency: Transforming Burnout to Resilience at a National Cancer Institute (NCI) Comprehensive Cancer Center
Dr. Amy Gallagher, PsyD, MSHCT, Author
Tags: Member Institution Quality Improvement
View Poster


Explore how Roswell Park Comprehensive Cancer Center developed a Division for Employee Resiliency. Learn how organizational assessments, strategic planning, and wellness programming help to enhance organizational resilience and strive to prevent employee burnout.

https://jnccn.org/view/journal...



Author(s):
  • Dr. Amy Gallagher, PsyD, MSHCT

Tags: Member Institution Quality Improvement
MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular CarcinomaMC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma
MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma
Nguyen H. Tran, MD, Author
Tags: Member Institution Clinical Oncology ORP
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Nguyen H. Tran, MD

Tags: Member Institution Clinical Oncology ORP
Demographic Changes of Expanded 2021 Lung Cancer Screening Guidelines in a Large National DatabaseDemographic Changes of Expanded 2021 Lung Cancer Screening Guidelines in a Large National Database
Demographic Changes of Expanded 2021 Lung Cancer Screening Guidelines in a Large National Database
Dr. Annie L. Zhang, MD, Author
Tags: Member Institution EpidemiologyRisksPrevention
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Dr. Annie L. Zhang, MD

Tags: Member Institution EpidemiologyRisksPrevention
  • Displaying 1 - 10 of 37
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last